China Pharma Holdings (CPHI) has released an update to notify the public and investors about an entry into a material definitive agreement.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Pharma Holdings’ subsidiary Helpson has acquired an invention patent for a psoriasis treatment from inventor Lihua Li for $1.50 million in company stock. The deal includes additional technical services from the Transferor and a decade-long profit-sharing arrangement where Helpson will pay 10% of annual net profits from the product to the Transferor, conditional upon the product’s profitability.
For further insights into CPHI stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.